Objective: The clock genes Period (per) 1 and 2 are essential components in the generation and adjustment of biological circadian rhythms by the suprachiasmatic nucleus (SCN). Both genes are also rhythmically present in extrahypothalamic areas such as the hippocampus and cerebellum, considered subordinate oscillators. Several pathological conditions alter rhythmic biological phenomena, but the mechanisms behind these changes involving the clock genes are not well defined. The current study investigated changes in PER1 and PER2 immunoreactivity in the SCN, hippocampus, and cerebellum in a neuroinflammation model. Methods: Wistar rats received lipopolysaccharide (LPS) or vehicle intracerebroventricularly. The melatonin plasmatic content was quantified by ELISA to confirm the alterations in biological rhythms, and PER1 and PER2 immunoreactivities were analyzed in brain sections by immunohistochemistry. Results: In the SCN, intracerebroventricular LPS changed PER1 expression, increasing the number of PER1-immunoreactive (IR) cells at zeitgeber time (ZT) 15, decreasing it at ZT5 and ZT20 and not changing it at ZT10. LPS also induced a decrease in PER2-IR cells at ZT5, ZT10, and ZT15 but not at ZT20 in the SCN. In the hippocampus, LPS induced a decrease in PER1-IR and PER2-IR cells at both ZTs (ZT10 and ZT15). In the cerebellum, LPS increased the number of PER1-IR cells at ZT10 and decreased it at ZT15, while the number of PER2-IR cells was reduced at both ZTs. Conclusions: These results indicate that a neuroinflammatory condition leads to desynchronization of primary and subordinate brain oscillators, supporting the existence of the integration between the immune and the circadian system.

Keywords:
Neuroinflammation, Circadian rhythms, Clock genes, Oscillators
1.
Lowrey PL, Takahashi JS: Genetics of the mammalian circadian system: photic entrainment, circadian pacemaker mechanisms, and posttranslational regulation. Annu Rev Genet 2000;34:533-562.
2.
Bae K, Jin X, Maywood ES, Hastings MH, Reppert SM, Weaver DR: Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock. Neuron 2001;30:525-536.
3.
Chun LE, Woodruff ER, Morton S, Hinds LR, Spencer RL: Variations in phase and amplitude of rhythmic clock gene expression across prefrontal cortex, hippocampus, amygdala, and hypothalamic paraventricular and suprachiasmatic nuclei of male and female rats. J Biol Rhythms 2015;30:417-436.
4.
Lamont EW, Robinson B, Stewart J, Amir S: The central and basolateral nuclei of the amygdala exhibit opposite diurnal rhythms of expression of the clock protein Period2. Proc Natl Acad Sci USA 2005;102:4180-4184.
5.
Harbour VL, Weigl Y, Robinson B, Amir S: Phase differences in expression of circadian clock genes in the central nucleus of the amygdala, dentate gyrus, and suprachiasmatic nucleus in the rat. PLoS One 2014;9: e103309.
6.
Okada K, Yano M, Doki Y, Azama T, Iwanaga H, Miki H, Nakayama M, Miyata H, Takiguchi S, Fujiwara Y, Yasuda T, Ishida N, Monden M: Injection of LPS causes transient suppression of biological clock genes in rats. J Surg Res 2008;145:5-12.
7.
Cavadini G, Petrzilka S, Kohler P, Jud C, Tobler I, Birchler T, Fontana A: TNF-alpha suppresses the expression of clock genes by interfering with E-box-mediated transcription. Proc Natl Acad Sci USA 2007;104:12843-12848.
8.
Yamamura Y, Yano I, Kudo T, Shibata S: Time-dependent inhibitory effect of lipopolysaccharide injection on Per1 and Per2 gene expression in the mouse heart and liver. Chronobiol Int 2010;27:213-232.
9.
Haimovich B, Reddell MT, Calvano JE, Calvano SE, Macor MA, Coyle SM, Lowry SF: A novel model of common Toll-like receptor 4- and injury-induced transcriptional themes in human leukocytes. Crit Care 2010;14:R177.
10.
Guan XT, Lin WJ, Tang MM: Comparison of stress-induced and LPS-induced depressive-like behaviors and the alterations of central proinflammatory cytokines mRNA in rats. Psych J 2015;4:113-122.
11.
Prendergast BJ, Cable EJ, Stevenson TJ, Onishi KG, Zucker I, Kay LM: Circadian disruption alters the effects of lipopolysaccharide treatment on circadian and ultradian locomotor activity and body temperature rhythms of female Siberian hamsters. J Biol Rhythms 2015;30:543-556.
12.
Gibbs JE, Ray DW: The role of the circadian clock in rheumatoid arthritis. Arthritis Res Ther 2013;15:205.
13.
Pinato L, da Silveira Cruz-Machado S, Franco DG, Campos LMG, Cecon E, Fernandes PA, Bittencourt JC, Markus RP: Selective protection of the cerebellum against intracerebroventricular LPS is mediated by local melatonin synthesis. Brain Struct Funct 2015;220:827-840.
14.
Markus RP, Ferreira ZS, Fernandes PA, Cecon E: The immune-pineal axis: a shuttle between endocrine and paracrine melatonin sources. Neuroimmunomodulation 2007;14:126-133.
15.
Kluger MJ: Fever: role of pyrogens and cryogens. Physiol Rev 1991;71:93-127.
16.
Banks WA, Gray AM, Erickson MA, Salameh TS, Damodarasamy M, Sheibani N, Meabon JS, Wing EE, Morofuji Y, Cook DG, Reed MJ: Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit. J Neuroinflammation 2015;12:223.
17.
Shi J, Zhao Y, Wang Y, Gao W, Ding J, Li P, Hu L, Shao F: Inflammatory caspases are innate immune receptors for intracellular LPS. Nature 2014;514:187-192.
18.
Remick DG, Newcomb DE, Bolgos GL, Call DR: Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide versus cecal ligation and puncture. Shock 2000;13:110-116.
19.
Campos LM, Cruz-Rizzolo RJ, Watanabe IS, Pinato L, Nogueira MI: Efferent projections of the suprachiasmatic nucleus based on the distribution of vasoactive intestinal peptide (VIP) and arginine vasopressin (AVP) immunoreactive fibers in the hypothalamus of Sapajus apella. J Chem Neuroanat 2014;57-58:42-53.
20.
Yu X, Li Z, Zheng H, Ho J, Chan MT, Wu WK: Protective roles of melatonin in central nervous system diseases by regulation of neural stem cells. Cell Prolif 2017;50:e12323.
21.
Marpegán L, Bekinschtein TA, Costas MA, Golombek DA: Circadian responses to endotoxin treatment in mice. J Neuroimmunol 2005;160:102-109.
22.
Guerrero-Vargas NN, Salgado-Delgado R, Basualdo Mdel C, García J, Guzmán-Ruiz M, Carrero JC, Escobar C, Buijs RM: Reciprocal interaction between the suprachiasmatic nucleus and the immune system tunes down the inflammatory response to lipopolysaccharide. J Neuroimmunol 2014;273:22-30.
23.
Smolensky MH, Lemmer B, Reinberg AE: Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma. Adv Drug Deliv Rev 2007;59:852-882.
24.
O'Callaghan EK, Anderson ST, Moynagh PN, Coogan AN: Long-lasting effects of sepsis on circadian rhythms in the mouse. PLoS One 2012;7:e47087.
25.
Ralph MR, Foster RG, Davis FC, Menaker M: Transplanted suprachiasmatic nucleus determines circadian period. Science 1990;247:975-978.
26.
Stoynev AG, Ikonomov OC, Damova IA, Penev PD, Usunoff KG, Paloff AM: Suprachiasmatic nuclei lesions eliminate light/dark variations in short-term feeding responses to deprivation or insulin treatment in rats. Physiol Behav 1990;48:795-799.
27.
Moriya S, Tahara Y, Sasaki H, Hamaguchi Y, Kuriki D, Ishikawa R, Ishigooka J, Shibata S: Effect of quetiapine on Per1, Per2, and Bmal1 clock gene expression in the mouse amygdala and hippocampus. J Pharmacol Sci 2014;125:329-332.
28.
Mordel J, Karnas D, Pévet P, Isope P, Challet E, Meissl H: The output signal of Purkinje cells of the cerebellum and circadian rhythmicity. PLoS One 2013;8:e58457.
29.
Curtis AM, Fagundes CT: Understanding the role of cellular molecular clocks in controlling the innate immune response. Methods Mol Biol 2016;1390:301-316.
30.
Castanon-Cervantes O, Wu M, Ehlen JC, Paul K, Gamble KL, Johnson RL, Besing RC, Menaker M, Gewirtz AT, Davidson AJ: Dysregulation of inflammatory responses by chronic circadian disruption. J Immunol 2010;185:5796-5805.
31.
Logan RW, Sarkar DK: Circadian nature of immune function. Mol Cell Endocrinol 2012;349:82-90.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.